CN105709068A - Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation - Google Patents
Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation Download PDFInfo
- Publication number
- CN105709068A CN105709068A CN201610181054.1A CN201610181054A CN105709068A CN 105709068 A CN105709068 A CN 105709068A CN 201610181054 A CN201610181054 A CN 201610181054A CN 105709068 A CN105709068 A CN 105709068A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- chinese medicine
- rhizoma
- medicine compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 208000024770 Thyroid neoplasm Diseases 0.000 title claims abstract description 38
- 201000002510 thyroid cancer Diseases 0.000 title claims abstract description 38
- 208000024891 symptom Diseases 0.000 title claims abstract description 28
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 230000002980 postoperative effect Effects 0.000 title abstract description 23
- 239000003053 toxin Substances 0.000 title abstract 3
- 231100000765 toxin Toxicity 0.000 title abstract 3
- 241000208368 Euonymus alatus Species 0.000 claims abstract description 9
- 208000033781 Thyroid carcinoma Diseases 0.000 claims description 31
- 208000013077 thyroid gland carcinoma Diseases 0.000 claims description 31
- 206010014080 Ecchymosis Diseases 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 241001250596 Pleione Species 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000011282 treatment Methods 0.000 abstract description 26
- 229940079593 drug Drugs 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 2
- 241000131329 Carabidae Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 244000248416 Fagopyrum cymosum Species 0.000 abstract 1
- 241000766380 Iphigenia Species 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000218206 Ranunculus Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 241000767840 Semiaquilegia Species 0.000 abstract 1
- 241000123725 Sophora tonkinensis Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 230000001934 delay Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 10
- 230000010354 integration Effects 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 201000010198 papillary carcinoma Diseases 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 201000009030 Carcinoma Diseases 0.000 description 3
- 206010033701 Papillary thyroid cancer Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 3
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000007054 Medullary Carcinoma Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000009261 endocrine therapy Methods 0.000 description 1
- 229940034984 endocrine therapy antineoplastic and immunomodulating agent Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 208000010576 undifferentiated carcinoma Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine, in particular to a traditional Chinese medicine compound for improving a thyroid cancer postoperative symptom of stasis toxin stagnation. According to the technical scheme for overcoming the defects of an existing western medicine treatment technology, the traditional Chinese medicine compound for improving the thyroid cancer postoperative symptom of stasis toxin stagnation is prepared from, by weight, fructus forsythiae, dandelions, chrysanthemum flowers, muskroot-like semiaquilegia roots, rhizoma paridis chinensis, airpotato yam rhizomes, wild buckwheat rhizomes, spreading hedyotis herb, barbed skullcap herb, Indian iphigenia bulbs, vietnamese sophora roots, manyleaf paris rhizomes, figwort roots, cortex moutan, radix paeoniae rubra, ground beetles, ternate buttercup roots, winged euonymus twigs and sun euphorbia herb. The traditional Chinese medicine compound is safe to use, accelerates postoperative rehabilitation of a patient, improves the life quality of the patient, prevents and delays recurrence and metastasis of a thyroid cancer, has good economic value and a clinical effect and is an innovation on postoperative rehabilitation treatment drugs of the thyroid cancer.
Description
Technical field
The present invention relates to medicine, particularly one improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card).
Background technology
Thyroid carcinoma is incidence malignant tumor more typically, accounts for l%～2% of whole body malignant tumor, common with women, it is seen that in any age bracket.The sickness rate of current thyroid carcinoma is in the notable trend risen year by year.Thyroid carcinoma is divided into the polytypes such as papillary adenocarcinoma, filter blocking cancer, undifferentiated carcinoma, medullary carcinoma.Wherein papillary carcinoma clinic is the most common, accounts for the 50%～70% of thyroid carcinoma.The Therapeutic Method of thyroid carcinoma has operative treatment, radiotherapy, chemotherapy, endocrine therapy and Chinese medicine etc..At present " suppression of operation+iodine 131 treatment+thyroxin " be acknowledged as the best comprehensive therapeutic plan of papillary carcinoma, it is possible to decrease recurrence or transfer incidence rate.Owing to papillary carcinoma belongs to low-grade malignant tumor, patient usually can ignore postoperative rehabilitation, and operation can only excise visible carcinoma, but can not eliminate the damage that human body is caused by carcinoma, and papillary carcinoma is postoperative higher in former operative site relapse rate.Therefore the rehabilitation that papillary carcinoma is postoperative should cause the attention of height.Increasing evidence shows at present, and postoperative Chinese medicine can improve the untoward reaction that operation itself brings；Improve immunity, accelerate patient postoperative rehabilitation；Alleviate the untoward reaction of oral thyroid element sheet；The softening postoperative cervical region projection cicatrix of thyroid carcinoma；Alleviate chemotherapy side effect；Suppress Elityran, reduce Serum Thyroglobulin, it is prevented that with recurrence and the transfer etc. that delay thyroid carcinoma.L thyroxine tab, because operation wound, visual area expose for a long time, anaesthetize the combined causes such as impact, tracheal intubation loss, operation position, postoperative long term positional, the treatment of postoperative iodine 131, hypothyroidism, causes patient to occur attacking outside wind heat, the various situations such as venation is impaired, qi depression to blood stasis, phlegm and blood stasis, wasting QI-blood body fluid, deficiency of both YIN and YANG.Postoperative pathogenesis many genus deficiency in origin and excess in superficiality, deficiency in origin is based on deficiency of qi and yin, and mark is real in the stagnation of QI, expectorant knot, blood stasis, liver-fire, ecchymosis, the two simulataneous insufficiency and excessive, reciprocal causation, common pathogenetic.Clinically visible deficiency of qi and blood, deficiency of qi and blood, expectorant knot blood stasis, deficiency of qi and blood, ecchymosis tie mutually, the pattern of syndrome such as deficiency of qi and blood, deficiency of qi and blood, deficiency of both YIN and YANG.Take wind and heat dispersing, depressed liver-energy dispersing and QI regulating to reduce phlegm accordingly, promoting flow of QI and blood blood stasis dispelling, hard masses softening and resolving, heat-clearing and toxic substances removing, Replenishing QI and nourishing YIN, benefiting qi and nourishing blood, the treatment such as nourishing YIN and invigorating YANG, to improving, thyroid carcinoma postsurgery symptoms effect is obvious, accelerate postoperative rehabilitation, improve patients ' life quality, it is prevented that with the recurrence and the transfer that delay thyroid carcinoma.Therefore, application Chinese medicine is the problem needing solution in thyroid carcinoma postoperative rehabilitation process badly.
Summary of the invention
Defect for above-mentioned existing western medical treatment technology, the purpose of the present invention is exactly the dialectical theory from Chinese medicine, one is provided to improve the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), the postoperative various clinical symptom of thyroid carcinoma can be effectively improved, accelerate postoperative rehabilitation, improve patients ' life quality, it is prevented that with the recurrence and the transfer that delay thyroid carcinoma；Solve to lack specificity therapeutic method, the problem causing patients ' life quality difference, thyroid carcinoma recurrence and transfer.
Its technical scheme solving problem is:
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card): by weighing scale: Fructus Forsythiae 10-20g, Herba Taraxaci 10-30g, Flos Chrysanthemi 10-20g, Radix Semiaquilegiae 10-20g, Rhizoma Paridis 10-30g, Rhizoma Dioscoreae Bulbiferae 6-10g, Rhizoma Fagopyri Dibotryis 10-20g, Herba Hedyotidis Diffusae 10-30g, Herba Scutellariae Barbatae 10-20g, Pseudobulbus Cremastrae Seu Pleiones 10-30g, Radix Sophorae Tonkinensis 10-20g, Rhizoma Paridis 10-20g, Radix Scrophulariae 10-30g, Cortex Moutan 10-30g, Radix Paeoniae Rubra 10-30g, Eupolyphaga Seu Steleophaga 10-20g, Radix Ranunculi Ternati 10-30g, winged euonymus 10-20g, Herba Euphorbiae Helioscopiae 10-20g makes；
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200-300ml, to obtain final product.
The pure traditional Chinese medicine of the present invention, it is main, compatibility heat removing and blood cooling medicine with antipyretic and antidotal type Chinese medicine, removing heat from blood and promoting blood circulation medicine, removing blood stasis disappears abdominal mass medicine, drug for invigorating blood circulation and eliminating stasis, utilize the giving consideration to both the incidental and fundamental of Chinese prescription, overall unified theory, all medicines match and can be effectively improved many clinical symptoms of thyroid carcinoma postoperative (ecchymosis retardance card), drug safety, accelerate patient postoperative rehabilitation, improve patients ' life quality, it is prevented that with the recurrence and the transfer that delay thyroid carcinoma, there are good economic worth and clinical effectiveness, are the innovation on thyroid carcinoma postoperative rehabilitation medicine.
Detailed description of the invention
Below in conjunction with embodiment, present disclosure is described in further detail:
Embodiment 1
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card): by weighing scale: Fructus Forsythiae 10g, Herba Taraxaci 10g, Flos Chrysanthemi 10g, Radix Semiaquilegiae 10g, Rhizoma Paridis 10g, Rhizoma Dioscoreae Bulbiferae 6g, Rhizoma Fagopyri Dibotryis 10g, Herba Hedyotidis Diffusae 10g, Herba Scutellariae Barbatae 10g, Pseudobulbus Cremastrae Seu Pleiones 10g, Radix Sophorae Tonkinensis 10g, Rhizoma Paridis 10g, Radix Scrophulariae 10g, Cortex Moutan 10g, Radix Paeoniae Rubra 10g, Eupolyphaga Seu Steleophaga 10g, Radix Ranunculi Ternati 10g, winged euonymus 10g, Herba Euphorbiae Helioscopiae 10g makes；
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200ml, to obtain final product.
Embodiment 2
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card): by weighing scale: Fructus Forsythiae 15g, Herba Taraxaci 20g, Flos Chrysanthemi 15g, Radix Semiaquilegiae 15g, Rhizoma Paridis 20g, Rhizoma Dioscoreae Bulbiferae 8g, Rhizoma Fagopyri Dibotryis 15g, Herba Hedyotidis Diffusae 20g, Herba Scutellariae Barbatae 15g, Pseudobulbus Cremastrae Seu Pleiones 20g, Radix Sophorae Tonkinensis 15g, Rhizoma Paridis 15g, Radix Scrophulariae 20g, Cortex Moutan 20g, Radix Paeoniae Rubra 20g, Eupolyphaga Seu Steleophaga 15g, Radix Ranunculi Ternati 20g, winged euonymus 15g, Herba Euphorbiae Helioscopiae 15g makes；
Its preparation method is: mixed by above-mentioned Chinese medicine, putting in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, use slow fire boiling instead 30 minutes, filtering, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 250ml, to obtain final product.
Embodiment 3
One improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card): by weighing scale: Fructus Forsythiae 20g, Herba Taraxaci 30g, Flos Chrysanthemi 20g, Radix Semiaquilegiae 20g, Rhizoma Paridis 30g, Rhizoma Dioscoreae Bulbiferae 10g, Rhizoma Fagopyri Dibotryis 20g, Herba Hedyotidis Diffusae 30g, Herba Scutellariae Barbatae 20g, Pseudobulbus Cremastrae Seu Pleiones 30g, Radix Sophorae Tonkinensis 20g, Rhizoma Paridis 20g, Radix Scrophulariae 30g, Cortex Moutan 30g, Radix Paeoniae Rubra 30g, Eupolyphaga Seu Steleophaga 20g, Radix Ranunculi Ternati 30g, winged euonymus 20g, Herba Euphorbiae Helioscopiae 20g makes；
Its preparation method is:
Being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 300ml, to obtain final product.
In said components, wherein:
Fructus Forsythiae
Nature and flavor: bitter, are slightly cold；
Gui Jing: return lung, the heart, gallbladder meridian；
Effect: heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation；
Cure mainly: for affection due to external wind and heat, epidemic febrile disease heating, skin infection swells and ache, scrofula.
Herba Taraxaci
Nature and flavor: bitter, sweet, cold；
Gui Jing: return liver, stomach warp；
Effect: heat-clearing and toxic substances removing, dampness removing；
Cure mainly: for pathopyretic ulcer, jaundice, pyretic stranguria, conjunctival congestion and swelling pain.
Flos Chrysanthemi
Nature and flavor: pungent, sweet, bitter, micro-Huang；
Gui Jing: return lung, Liver Channel；
Effect: dispelling wind and heat pathogens, liver heat removing and eyesight improving；
Cure mainly: for wind heat exterior syndrome, epidemic febrile disease from the beginning of, conjunctival congestion and swelling pain, order is secretly dim-sighted, the vertigo.
Radix Semiaquilegiae
Nature and flavor: sweet in the mouth, hardship, cold in nature；
Gui Jing: return liver, stomach warp；
Effect: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds；
Cure mainly: for carbuncle furuncle, acute mastitis, scrofula, snake bite and insect sting.
Rhizoma Paridis
Nature and flavor: bitter, are slightly cold, slightly poisonous；
Gui Jing: Liver Channel；
Effect: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. arresting convulsion；
Cure mainly: for carbuncle furuncle, venom, coma, twitch, traumatic hemorrhage, swelling and pain due to blood stasis.
Rhizoma Dioscoreae Bulbiferae
Nature and flavor: bitter, cold, poisonous；
Gui Jing: return spleen, Liver Channel；
Effect: vanishing sputum and dispelling knot, heat-clearing and toxic substances removing；
Cure mainly: vanishing sputum and dispelling knot, for goiter, scrofula, sucutaneous nodule.
Rhizoma Fagopyri Dibotryis
Nature and flavor: bitter are flat；
Gui Jing: return lung, spleen, stomach warp；
Effect: heat-clearing and toxic substances removing, reduces phlegm, strengthening the spleen to promote digestion；
Cure mainly: for lung abscess chest pain, cough due to lung-heat, scrofula furuncle and phyma, abdominal distention is eaten less, and infantile malnutrition is become thin.
Herba Hedyotidis Diffusae
Nature and flavor: mildly bitter flavor, cold in nature；
Gui Jing: stomach, large intestine, small intestine meridian；
Effect: heat-clearing and toxic substances removing, dampness removing is treating stranguria；
Cure mainly: for dyspnea and cough due to lung-heat, laryngopharynx swelling and pain, acute appendicitis, furuncle and phyma skin infection, venom, the puckery pain of pyretic stranguria, edema, dysentery, enteritis, jaundice due to damp-heat, cancerous protuberance.
Herba Scutellariae Barbatae
Nature and flavor: pungent, bitter, cold；
Gui Jing: return lung, liver, kidney channel；
Function: heat-clearing and toxic substances removing, blood stasis dispelling diuresis；
Cure mainly: for furuncle swelling toxin, laryngopharynx swelling and pain, venom, fall and flutter the pain of injury, edema, jaundice.
Pseudobulbus Cremastrae Seu Pleiones
Nature and flavor: sweet, micro-pungent are cool；
Gui Jing: return liver, spleen channel；
Function: heat-clearing and toxic substances removing, dissipating phlegm and resolving masses；
Cure mainly: for carbuncle furunculosis, scrofula sucutaneous nodule, tuberculous lymphadenitis, snake bite and insect sting.
Radix Sophorae Tonkinensis
Nature and flavor: bitter, cold；
Gui Jing: attach to the lung and stomach meridians；
Effect: heat-clearing and toxic substances removing, relieving sore throat and diminishing swelling；
Cure mainly: for laryngopharynx swelling and pain, cough due to lung-heat, carbuncle sore tumefacting virus.
Rhizoma Paridis
Nature and flavor: micro-hardship, cool, slightly poisonous；
Gui Jing: Liver Channel；
Effect: heat-clearing and toxic substances removing, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. arresting convulsion；
Effect: swell and ache for tonsillitis, acute and chronic tonsillitis, for temperature poison mumps, parotitis, for damp and hot fulminant leucorrhagia with yellowish discharge, carbuncle is controlled in detumescence, antidotes against snake bite, removing heat in the liver to subdue the wind syndrome.
Radix Scrophulariae
Nature and flavor: bitter, sweet, salty, cold；
Gui Jing: lung, stomach, kidney channel；
Effect: clearing away heat and cooling blood, detoxicating and resolving stagnation of pathogens, Yin-nourishing and body fluid promoting；
Cure mainly: joining the army point for heat, fever aggravated at night, heat in blood sends out speckle, laryngopharynx swelling and pain, carbuncle sore tumefacting virus, dryness of the intestine constipation.
Cortex Moutan
Nature and flavor: bitter, pungent, are slightly cold；
Gui Jing: GUIXIN, liver, stomach warp；
Effect: clearing away heat and cooling blood, promoting blood circulation to remove blood stasis, moves back steaming；
Curing mainly: tell nosebleed for heat in blood, send out speckle, yin asthenia generating intrinsic heat, lossless hectic fever due to YIN-deficiency, amenorrhea dysmenorrhea, traumatic injury, skin infection swells and ache, abdominalgia with intestinal abscess.
Radix Paeoniae Rubra
Nature and flavor: bitter, are slightly cold；
Gui Jing: Liver Channel；
Effect: clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, pain relieving；
Cure mainly: for bleeding due to blood-heat, tell nosebleed and send out speckle, blood stasis amenorrhea, traumatic injury, pathopyretic ulcer, liver-fire conjunctival congestion.
Eupolyphaga Seu Steleophaga
Nature and flavor: salty, cold, slightly poisonous；
Gui Jing: Liver Channel；
Effect: removing blood stasis, reunion of fractured tendons and bones；
Cure mainly: for amenorrhea, abdominal mass, postpartum stagnation, the fracture pain of injury.
Radix Ranunculi Ternati
Nature and flavor: sweet, acrid, warm；
Gui Jing: return liver, lung meridian；
Function: eliminating stagnation, detumescence；
Cure mainly:, tuberculous lymphadenitis not routed for scrofula.
Winged euonymus
Nature and flavor: bitter, cold；
Gui Jing: Liver Channel；
Function: promoting the circulation of blood is stimulated the menstrual flow, eliminating stasis to stop pain；
Cure mainly: for menoxenia, curing postpartum bleeding is suffered from abdominal pain, and traumatic injury swells and ache.
Herba Euphorbiae Helioscopiae
Nature and flavor: pungent, bitter, are slightly cold, poisonous；
Gui Jing: return lung, small intestinal, large intestine channel；
Function: inducing diuresis to remove edema, dissipating phlegm and resolving masses, parasite killing.
Cure mainly: for edema, cirrhotic ascites, bacillary dysentery；Tuberculous lymphadenitis, Tuberculous fistula, neurodermatitis are controlled in external.And can go out maggot, wriggler.
Above-mentioned component science, reasonable compatibility, support mutually, has effect of heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation, is effective to treatment thyroid carcinoma, good effect, drug safety, and obtains through clinical data and fully prove, relevant clinical data is as follows:
(1), the inclusion criteria of thyroid cancer patients:
All cases is all made a definite diagnosis through preoperative B ultrasonic, thyroid radioisotope scanning or needle biopsy, and selects for thyroid carcinoma through verified by postoperative pathology diagnosis.Accompany or without abnormal thyroid function.
(2), the exclusion standard of thyroid cancer patients:
Gestation, women breast-feeding their children, abnormal liver function person；It is associated with the severe primary diseases such as cardiovascular, liver, kidney and hemopoietic system, psychotic；Accept other Chinese medicines, glucocorticoid and other immunosuppressant treatment person；Other drug clinical trial person is participated in nearly March.
(3), efficacy assessment standard:
Comprehensive therapeutic effect criterion: computing formula: (treatment foreset divide and rule treatment after integration)/treatment before integration, be expressed as a percentage.Recovery from illness: symptom and sign disappears substantially, and integration is more than or equal to 95%；Effective: symptom and sign is obviously improved, integration integration is more than or equal to 75%；Effective: symptom and sign take a favorable turn, integration is more than or equal to 50%；Invalid: symptom and sign is not improved, even increase the weight of, integration is less than 50%.
(4), therapeutic scheme:
To the patient that diagnosis is thyroid carcinoma, treating with the Chinese medicine of the present invention, when taking, sooner or later respectively once, each 100-150ml, two hours after meal cool clothes, 7 days are a course for the treatment of, add up curative effect after 4 courses for the treatment of.
(5), statistical procedures:
Selected thyroid cancer patients totally 35 example, wherein male 30 examples, female 5 example, the age is (32.1 ± 6.2) year.By above-mentioned (four) therapeutic scheme, the Chinese medicine that the oral present invention provides, add up after 4 courses for the treatment of, effective 24 examples of clinical recovery, effective 8 examples, effective 3 examples, total effective rate reaches 100.0%, it was shown that this invention treatment by Chinese herbs thyroid carcinoma effect is notable, has reached clinical treatment purpose, and over the course for the treatment of, have no obvious adverse reaction.
In order to more detailed description treats situation, the curative effect situation of model case given below and treatment:
Case 1:
Zhang, man, 28 years old, build was fat, usually short-tempered.Diagnosis is thyroid papillary carcinoma, and row thyroid cuts operative treatment entirely.Occurring operative site congestion and swelling pain, tenderness after performing the operation 1 week, tenderness is obvious, without oozing out, irritable, irritability, and xerostomia is thirsty, dry laryngopharynx pain, red tongue with yellowish and greasy fur, arteries and veins flood.After taking 1 course for the treatment of of this Chinese medicine, patient's above-mentioned symptom alleviates gradually；After 3 courses for the treatment of, symptom and sign disappears substantially.
Case 2:
Money, man, 41 years old, usually like to drink, eating greasy food.Diagnosis is left side thyroid papillary carcinoma, and within postoperative 1 week, operative site congestion and swelling pain increases the weight of gradually, tenderness, and tenderness is obvious, uncomfortable in chest, thirsty, desire for cold drinks, and throat is sticky, coughs and tells yellow viscous expectorant.Red tongue with yellowish and greasy fur, slippery and rapid pulse.After taking 2 courses for the treatment of of this Chinese medicine, patient's above-mentioned symptom alleviates gradually；After 4 courses for the treatment of, symptom and sign disappears substantially.
Case 3:
Lee, man, 32 years old, usually short-tempered, like maror, constipation with dry stool, have hemorrhoid.Diagnosis is thyroid papillary carcinoma, and row right thyroid time cuts operative treatment entirely.Occurring after leaving hospital 3 days that operative site is red and swollen, pain is obvious, tenderness, and tenderness is obvious, thirsty, constipation with dry stool band blood, yellow urine.Red tongue with yellow fur is dry, rapid pulse.After taking 2 courses for the treatment of of this Chinese medicine, patient's above-mentioned symptom alleviates gradually；After 5 courses for the treatment of, symptom and sign disappears substantially.
(6), conclusion
Being shown by above-mentioned situation, the present invention is the active drug for improving thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), and effective percentage reaches 100.0%, has no side effect, and stable curative effect is safe and reliable, and clinical meaning is huge.
Claims (4)
1. the Chinese medicine compound improving thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), it is characterized in that: this compound recipe is by weighing scale: Fructus Forsythiae 10-20g, Herba Taraxaci 10-30g, Flos Chrysanthemi 10-20g, Radix Semiaquilegiae 10-20g, Rhizoma Paridis 10-30g, Rhizoma Dioscoreae Bulbiferae 6-10g, Rhizoma Fagopyri Dibotryis 10-20g, Herba Hedyotidis Diffusae 10-30g, Herba Scutellariae Barbatae 10-20g, Pseudobulbus Cremastrae Seu Pleiones 10-30g, Radix Sophorae Tonkinensis 10-20g, Rhizoma Paridis 10-20g, Radix Scrophulariae 10-30g, Cortex Moutan 10-30g, Radix Paeoniae Rubra 10-30g, Pseudobulbus Cremastrae Seu Pleiones 10-30g, Eupolyphaga Seu Steleophaga 10-20g, Radix Ranunculi Ternati 10-30g, winged euonymus 10-20g, Herba Euphorbiae Helioscopiae 10-20g makes；
Its preparation method is:
Wherein, being mixed by above-mentioned Chinese medicine, put in container, add 1000ml water soaking half an hour, intense fire decocts to boiling, using slow fire boiling instead 30 minutes, filter, obtain filtrate, filtering residue adds 800ml water and decocts once again, filter, obtain filtrate, twice filtrate mixing is concentrated into 200-300ml, to obtain final product.
2. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), it is characterised in that: this compound recipe is by weighing scale: Fructus Forsythiae 10g, Herba Taraxaci 10g, Flos Chrysanthemi 10g, Radix Semiaquilegiae 10g, Rhizoma Paridis 10g, Rhizoma Dioscoreae Bulbiferae 6g, Rhizoma Fagopyri Dibotryis 10g, Herba Hedyotidis Diffusae 10g, Herba Scutellariae Barbatae 10g, Pseudobulbus Cremastrae Seu Pleiones 10g, Radix Sophorae Tonkinensis 10g, Rhizoma Paridis 10g, Radix Scrophulariae 10g, Cortex Moutan 10g, Radix Paeoniae Rubra 10g, Pseudobulbus Cremastrae Seu Pleiones 10g, Eupolyphaga Seu Steleophaga 10g, Radix Ranunculi Ternati 10g, winged euonymus 10g, Herba Euphorbiae Helioscopiae 10g makes.
3. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), it is characterised in that: this compound recipe is by weighing scale: Fructus Forsythiae 15g, Herba Taraxaci 20g, Flos Chrysanthemi 15g, Radix Semiaquilegiae 15g, Rhizoma Paridis 20g, Rhizoma Dioscoreae Bulbiferae 8g, Rhizoma Fagopyri Dibotryis 15g, Herba Hedyotidis Diffusae 20g, Herba Scutellariae Barbatae 15g, Pseudobulbus Cremastrae Seu Pleiones 20g, Radix Sophorae Tonkinensis 15g, Rhizoma Paridis 15g, Radix Scrophulariae 20g, Cortex Moutan 20g, Radix Paeoniae Rubra 20g, Pseudobulbus Cremastrae Seu Pleiones 20g, Eupolyphaga Seu Steleophaga 15g, Radix Ranunculi Ternati 20g, winged euonymus 15g, Herba Euphorbiae Helioscopiae 15g makes.
4. one according to claim 1 improves the Chinese medicine compound of thyroid carcinoma postsurgery symptoms (ecchymosis retardance card), it is characterised in that: this compound recipe is by weighing scale: Fructus Forsythiae 20g, Herba Taraxaci 30g, Flos Chrysanthemi 20g, Radix Semiaquilegiae 20g, Rhizoma Paridis 30g, Rhizoma Dioscoreae Bulbiferae 10g, Rhizoma Fagopyri Dibotryis 20g, Herba Hedyotidis Diffusae 30g, Herba Scutellariae Barbatae 20g, Pseudobulbus Cremastrae Seu Pleiones 30g, Radix Sophorae Tonkinensis 20g, Rhizoma Paridis 20g, Radix Scrophulariae 30g, Cortex Moutan 30g, Radix Paeoniae Rubra 30g, Pseudobulbus Cremastrae Seu Pleiones 30g, Eupolyphaga Seu Steleophaga 20g, Radix Ranunculi Ternati 30g, winged euonymus 20g, Herba Euphorbiae Helioscopiae 20g makes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610181054.1A CN105709068A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610181054.1A CN105709068A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105709068A true CN105709068A (en) | 2016-06-29 |
Family
ID=56159118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610181054.1A Pending CN105709068A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105709068A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145151A (en) * | 2011-04-15 | 2011-08-10 | 张龙标 | Chinese medicinal herb composition for treating cancers |
| CN103705862A (en) * | 2014-01-06 | 2014-04-09 | 河南中医学院 | Traditional Chinese medicine for relieving symptoms of qi depression and phlegm obstruction after thyroid cancer surgery |
-
2016
- 2016-03-28 CN CN201610181054.1A patent/CN105709068A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145151A (en) * | 2011-04-15 | 2011-08-10 | 张龙标 | Chinese medicinal herb composition for treating cancers |
| CN103705862A (en) * | 2014-01-06 | 2014-04-09 | 河南中医学院 | Traditional Chinese medicine for relieving symptoms of qi depression and phlegm obstruction after thyroid cancer surgery |
Non-Patent Citations (1)
| Title |
|---|
| 李成卫，等: "《恶性肿瘤名家传世灵验药对》", 31 March 2010, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103656041B (en) | A kind of Chinese medicine for the treatment of cervical cancer | |
| CN103705863B (en) | A kind of Chinese medicine improving the postoperative syndrome of deficiency of both qi and yin of thyroid carcinoma | |
| CN103656539B (en) | A kind of Chinese medicine improving excessive liver fire syndrome after thyroid carcinoma surgery | |
| CN103690763B (en) | A kind of Chinese medicine improving the postoperative wind heat of thyroid carcinoma and violate exterior syndrome | |
| CN102935205B (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN104288745A (en) | Traditional Chinese medicine for treating CG (Chronic Gastritis) | |
| CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
| CN103432269B (en) | Chinese medicinal preparation used for treating radiation enteritis | |
| CN103212026B (en) | A kind of Chinese medicine for the treatment of cholelithiasis and preparation method thereof and instructions of taking | |
| CN105709068A (en) | Traditional Chinese medicine compound for improving thyroid cancer postoperative symptom of stasis toxin stagnation | |
| CN103893432A (en) | Pharmaceutical composition for treating fracture and soft tissue injury and preparation method of pharmaceutical composition | |
| CN104491060A (en) | Tradtional Chinese medicine for preventing relapse of glioma | |
| CN103520653B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN106938031A (en) | A kind of medicine of thyroid adenoma | |
| CN106256371A (en) | A kind of Chinese medicine composition treating blood stasis type abdominal mass and preparation method thereof | |
| CN105999060A (en) | Traditional Chinese medicine composition for treating blood stasis type of female abdominal mass and preparation method thereof | |
| CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN105456617A (en) | Oral-administrated traditional Chinese medicine pills for treating symptom of pathogenic fire derived from stagnation of liver and preparation method thereof | |
| CN104998189A (en) | Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof | |
| CN105434533A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN105125836A (en) | Decoction medicament for treating erythema nodosum and preparation method thereof | |
| CN105287798A (en) | Lipid-lowering and slimming recovery pill | |
| CN105056111A (en) | Traditional Chinese medicinal pill for treating hodgkin lymphoma | |
| CN105194429A (en) | Traditional Chinese medicine for treating bronchial asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160629 |
|
| WD01 | Invention patent application deemed withdrawn after publication |